[18F]ACI-15916 PET in α-synucleinopathies

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Parkinson's Disease (PD) · Multiple System Atrophy (MSA) · Dementia With Lewy Bodies (DLB)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Karolinska Institutet, Solna, Sweden
Contact: Study coordinator (Andrea Varrone) · andrea.varrone@ki.se · (+46) 070-744 27 28
Contact: Study coordinator (Zarah Gander) · zarah.gander@ki.se · (+46) 070-266 67 14
Contact: Principal Investigator (Andrea Varrone, Prof.)

Study leads

Andrea Varrone, Prof.
Principal Investigator
Karolinska Institutet

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA

Multiple System Atrophy (MSA) · Parkinson's Disease (PD)

Abroad (travel likely)RecruitingPHASE1

Wuxi, China · Shanghai, China

Comprehensive Assessment of Neurodegeneration and Dementia

Dementia · Mild Cognitive Impairment (MCI) · Subjective Cognitive Impairment

Abroad (travel likely)Recruiting

Calgary, Canada · Edmonton, Canada

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

Parkinson's Disease (PD) · Mild to Moderate Parkinson's Disease · Early Stage Parkinson's Disease

Abroad (travel likely)RecruitingPHASE1

Lille, France · Liverpool, United Kingdom

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Parkinson's Disease

Abroad (travel likely)RecruitingPHASE1

Austin, United States · Tōon, Japan